Showing 39,981 - 40,000 results of 107,296 for search '(( i w decrease ) OR ( 5 ((point decrease) OR (((mean decrease) OR (a decrease)))) ))', query time: 2.05s Refine Results
  1. 39981

    LC MS/MS proteomic analysis of mouse proteins in vaginal brush samples that are down-regulated in response to treatment with N9 (open, black circles) or BZK (closed squares). by Scott Fields (12226)

    Published 2014
    “…<p>Shown are proteins that were decreased relative to vehicle controls. The following proteins are shown: peptidoglycan recognition protein 1 (PGLYRP-1), mucin 5 subtype B (mucin 5B), destrin, and carbonyl reductase 3 (CAR3). …”
  2. 39982
  3. 39983
  4. 39984

    Lentivirally-mediated modulation of ZO-1 and ZONAB expression. by Anastasios Georgiadis (358189)

    Published 2013
    “…<p>Retinal cryosections were obtained from eyes 5 days after the subretinal injections of LNT.shGFP (<b>A,B</b>), LNT.ZONAB (<b>C,D</b>) or LNT.shZO-1 (<b>E,F</b>) at 10<sup>7</sup> T.U.…”
  5. 39985
  6. 39986
  7. 39987
  8. 39988

    Cardiac Dysfunction in a Porcine Model of Pediatric Malnutrition by Christian Fabiansen (814979)

    Published 2015
    “…Plasma pro-atrial natriuretic peptide decreased in both MAIZE and AGE-REF during the first 3 weeks but increased markedly in MAIZE relative to AGE-REF during week 5–7 (p≤0.001). …”
  9. 39989
  10. 39990

    Preparation and NMR Spectra of the (Trifluoromethyl)argentates(III) [Ag(CF<sub>3</sub>)<i><sub>n</sub></i>X<sub>4-<i>n</i></sub><i></i>]<sup>-</sup>, with X = CN (<i>n</i> = 1−3),... by Reint Eujen (2973468)

    Published 1997
    “…In the [Ag(CF<sub>3</sub>)<sub>3</sub>(CH<sub>3</sub>)]<sup>-</sup> anion, the Ag−CH<sub>3</sub> distance (2.097(5) Å) is slightly shorter than the average Ag−CF<sub>3</sub> bond lengths (2.119(10) Å).…”
  11. 39991

    Attaining the Utmost Stability and Energy of Carbonyl Azides by the Synergistic Improvement of Conjugation and H-bonding by Baojing Tian (19941820)

    Published 2024
    “…In this study, we present a new family of carbonyl azides, 5-nitro-1H-1,2,4-triazol-3-yl-carbamoyl-azide (NTCA), which was synthesized through in situ oxidation cleavage of amino-tetrazole. …”
  12. 39992
  13. 39993

    Synthetic Control of Excited-State Properties in Cyclometalated Ir(III) Complexes Using Ancillary Ligands by Jian Li (41607)

    Published 2005
    “…The Ir−C<sub>aryl</sub> bond lengths in (<i>tpy</i>)<sub>2</sub>Ir(CN-<i>t-</i>Bu)<sub>2</sub><sup>+</sup> (2.047(5) and 2.072(5) Å) and (<i>tpy</i>)<sub>2</sub>Ir(PPh<sub>2</sub>CH<sub>2</sub>)<sub>2</sub>BPh<sub>2</sub> (2.047(9) and 2.057(9) Å) are longer than their counterparts in (<i>tpy</i>)<sub>2</sub>Ir(acac) (1.982(6) and 1.985(7) Å). …”
  14. 39994

    Synthetic Control of Excited-State Properties in Cyclometalated Ir(III) Complexes Using Ancillary Ligands by Jian Li (41607)

    Published 2005
    “…The Ir−C<sub>aryl</sub> bond lengths in (<i>tpy</i>)<sub>2</sub>Ir(CN-<i>t-</i>Bu)<sub>2</sub><sup>+</sup> (2.047(5) and 2.072(5) Å) and (<i>tpy</i>)<sub>2</sub>Ir(PPh<sub>2</sub>CH<sub>2</sub>)<sub>2</sub>BPh<sub>2</sub> (2.047(9) and 2.057(9) Å) are longer than their counterparts in (<i>tpy</i>)<sub>2</sub>Ir(acac) (1.982(6) and 1.985(7) Å). …”
  15. 39995

    Advanced Hard Ctings: Towards A Whole New World by Santecchia, Eleonora

    Published 2014
    “…That is where advanced surface coatings come in. From a manufacturing point of view, tools for machining are of particular interest. …”
    Get full text
    Get full text
  16. 39996
  17. 39997

    VP1 interferes with the effector phase of the RNAi pathway. by Joël T. van Mierlo (142169)

    Published 2012
    “…Radiolabeled siRNAs were incubated in buffer (lane 1) or with decreasing amounts of recombinant MBP-VP1<sup>ΔN284</sup> (lanes 2–5), MBP (lanes 6–9), and MBP-NS3 (lane 10–13). …”
  18. 39998

    The difference in outcome parameters between groups. by Mi-yeon Yu (813778)

    Published 2017
    “…<p>Outcome parameters represent the followings; O1, decrease of time-averaged proteinuria from trial phase and to the observational phase; O2, remission of UPCR <0.2 g/g cr during observational phase; O3, rapid decline of eGFR ≥5 mL/min/1.73 m<sup>2</sup> during observational phase; O4, composite outcome of increase in serum cr level (≥50% from baseline) noted during observational phase or deterioration of renal function to end stage renal disease. …”
  19. 39999
  20. 40000